CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

4-oxalomesaconate tautomerase

class of enzymes

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionAug 26, 2023
Entity authorityQ13415335 ↗
Source-derived summary

4-oxalomesaconate tautomerase (EC 5.3.2.8, GalD) is an enzyme with systematic name 4-oxalomesaconate keto---enol-isomerase. This enzyme catalyses the following chemical reaction

(1E)-4-oxobut-1-ene-1,2,4-tricarboxylate

⇌

{\displaystyle \rightleftharpoons }

(1E,3E)-4-hydroxybuta-1,3-diene-1,2,4-tricarboxylate

This enzyme has been characterized from the bacterium Pseudomonas putida.

Editorial summary

“4-oxalomesaconate tautomerase” enters the record as class of enzymes. Crown Archives preserves that source wording while asking what 4-oxalomesaconate, tautomerase and class can confirm, complicate or overturn.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current 36-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. Its strongest next move is a source search built around 4-oxalomesaconate, tautomerase and class.
Editorial analysis

Why this record matters

“4-oxalomesaconate tautomerase” is worth following because a concise public description often conceals a longer documentary argument. Here, 4-oxalomesaconate, tautomerase and class provides the most credible route into that argument.

Evidence profile

Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Aug 26, 2023. The linked authority identifier is Q13415335. None of the 0 selected statements returned an explicit reference.

Critical limits

Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “4-oxalomesaconate tautomerase”, its source revision and the description used here.
  2. Expand the search: follow 4-oxalomesaconate tautomerase primary sources, 4-oxalomesaconate tautomerase archive and 4-oxalomesaconate research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “4-oxalomesaconate tautomerase”?
  2. Which cited source is closest to the event, object or claim?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “4-oxalomesaconate tautomerase” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.